BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33144466)

  • 21. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
    Wang Y; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Shi HX; Zhang YC; Wang JZ; Zhang XU; Chen Y; Huang XJ; Lu DP
    Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):903-6. PubMed ID: 18261271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
    Gifford G; Sim J; Horne A; Ma D
    Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The time-dependent effects of early-onset Epstein-Barr viremia on adult acute leukemia patients following allo-HSCT with ATG-containing MAC regimen.
    Ke P; Zhang X; Liu S; Zhu Q; Ma X; Chen F; Tang X; Han Y; Fu Z; Chen S; Wu D; Qiu H; Zhou J; Bao X
    Ann Hematol; 2021 Jul; 100(7):1879-1889. PubMed ID: 33885923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex Vivo CD34
    Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation.
    Gruber I; Koelbl O; Herr W; Holler E; Edinger M; Wolff D
    Radiat Oncol; 2022 Nov; 17(1):195. PubMed ID: 36447269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma.
    Maloney DG
    Leuk Lymphoma; 2003; 44 Suppl 3():S99-105. PubMed ID: 15202532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Second allogeneic transplant for leukemia relapsed after first allogeneic transplantation].
    Yang DL; Han MZ; Feng SZ; Wang M; Zou DH; Wei JL; Yan ZS; Zhou SY; Liu QG; Jiang EL; Huang Y; Wang HH; Zhou Z; Zhai WJ; Yan WW; Han ZC
    Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):285-9. PubMed ID: 15182537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Yu ZP; Ding JH; Chen BA; Liu BC; Liu H; Li YF; Ding BH; Qian J
    Chin J Cancer; 2010 Nov; 29(11):946-51. PubMed ID: 20979694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of second hematopoietic stem cell transplantation using reduced-intensity conditioning in an outpatient setting.
    Jaime-Pérez JC; Picón-Galindo E; Herrera-Garza JL; Gómez-Almaguer D
    Hematol Oncol; 2021 Feb; 39(1):87-96. PubMed ID: 32978807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.
    Abou-Mourad YR; Lau BC; Barnett MJ; Forrest DL; Hogge DE; Nantel SH; Nevill TJ; Shepherd JD; Smith CA; Song KW; Sutherland HJ; Toze CL; Lavoie JC
    Bone Marrow Transplant; 2010 Feb; 45(2):295-302. PubMed ID: 19597425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
    Alanazi W; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Al-Shaibani Z; Mattsson J; Michelis FV
    Acta Haematol; 2021; 144(1):66-73. PubMed ID: 32428903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
    Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
    Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
    Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
    Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH
    Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia.
    Tan J; Wang Y; Yu SJ; Ma YY; Lei HY; Liu QF
    Leuk Res; 2017 Aug; 59():1-7. PubMed ID: 28527401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impacts of post-transplantation cyclophosphamide treatment after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Namdaroglu S; Kaya AH; Batgi H; Kayikci O; Dal MS; Iskender D; Kizil Cakar M; Tekgunduz E; Altuntas F
    Sci Rep; 2019 Feb; 9(1):2046. PubMed ID: 30765830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Yuda S; Fuji S; Onishi A; Tanaka T; Inamoto Y; Kurosawa S; Kim SW; Fukuda T
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1152-1157. PubMed ID: 30660773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.